#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Amyloidosis Mucopolysaccharidosis III Erdheim-Chester disease Small cell lung cancer Basal cell naevus syndrome Glycogen storage disease type II Mitochondrial DNA depletion Paraganglion neoplasm Aicardi-Goutieres syndrome Cutaneous calcification Restless legs syndrome Subdural haematoma Familial dilated cardiomyopathy Glioma Gastrooesophageal cancer More trials…

    Learn about Rare Diseases

    Osteosarcoma recurrent – Diagnostics Pleural mesothelioma malignant – Trials in Disease Glycogen storage disease type I – Diagnostics Primary hyperoxaluria Factor IX deficiency – Treatment Mucopolysaccharidosis – Diagnostics Progressive supranuclear palsy – Life with Disease Glomerulonephritis membranous – Trials in Disease Myxofibrosarcoma – Trials in Disease Glycogen storage disease type V – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tarlatamab IBUZATRELVIR Alxn2220 Bcmacp03 Obeticholic Acid Lurasidone Gentamicin Sulfate Rasburicase Db-1303 Hdp-101 Axitinib TRAZODONE HYDROCHLORIDE Mps-216 Volrustomig Rimegepant Selumetinib Myrrh Propylene Glycol Iclepertin Evx-01 More therapies…

    Learn about Your Condition

    Acoustic neuroma Aneurysm ruptured Somatic symptom disorder Cervix carcinoma Hepatoblastoma Arterial disorder Diabetes mellitus Oral neoplasm Procedural headache Genital herpes simplex Substance use disorder Cerebellar ataxia BK virus infection Alcoholic liver disease Biopsy heart More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Hippokration Hospital

Hippokration Hospital

Vassilissas Sofias Avenue 114, Athens, 115 27, Greece

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Vericiguat for Adults with Chronic Heart Failure with Reduced Ejection Fraction

    Not recruiting

    3 1
    Investigated Diseases:
    • Heart failure with reduced ejection fraction
    Investigated Drugs:
    • Vericiguat
    Austria Czechia Denmark France Germany Greece +6

  • Study on the Effectiveness and Safety of Deucravacitinib for Patients with Active Systemic Lupus Erythematosus (SLE)

    Not recruiting

    3 1
    Investigated Drugs:
    • Deucravacitinib
    Bulgaria Czechia Greece Hungary Poland Portugal +1

  • Study on the Effects of Filgotinib for Adults with Active Axial Spondyloarthritis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Axial spondyloarthritis
    Investigated Drugs:
    • Filgotinib
    Belgium Bulgaria Croatia Czechia Estonia France +9

  • Study on Ravulizumab for Protecting Chronic Kidney Disease Patients from Acute Kidney Injury After Heart Surgery

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Acute kidney injury
    Investigated Drugs:
    • Ravulizumab
    France Germany Greece Italy The Netherlands Poland +2

  • Study on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis

    Not recruiting

    3 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Obefazimod
    Austria Belgium Bulgaria Czechia France Germany +7

  • Study Comparing Risankizumab and Ustekinumab for Adults with Moderate to Severe Crohn’s Disease After Anti-TNF Therapy Failure

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Risankizumab
    • Ustekinumab
    Austria Belgium Bulgaria Czechia France Germany +8

  • Study on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Clopidogrel
    • Milvexian
    Austria Belgium Bulgaria Croatia Czechia Denmark +16

  • Study on Luspatercept for Treating Anemia in Adults and Adolescents with Alpha-Thalassemia

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Luspatercept
    Greece Italy

  • Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Clopidogrel
    • Milvexian
    Austria Belgium Bulgaria Croatia Czechia Denmark +14

  • Study on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Andexanet Alfa
    • Apixaban
    • Milvexian
    Belgium Bulgaria Croatia Czechia Denmark Estonia +13
Previous Page
1 … 10 11 12 13 14
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!